Healthcare stock under pressure: Spark Therapeutics Inc(NASDAQ: ONCE)
Spark Therapeutics Inc(NASDAQ: ONCE) lost over 7.8% on Feb 20th, 2018 hurt by their weak top line for the year ended December 31, 2017, which…
Spark Therapeutics Inc(NASDAQ: ONCE) lost over 7.8% on Feb 20th, 2018 hurt by their weak top line for the year ended December 31, 2017, which…
Spark Therapeutics Inc(NASDAQ: ONCE) stock got downgraded by analysts from Goldman from Buy to a Neutral rating. Spark Therapeutics stock crashed over 35.9% in the…
Spark Therapeutics Inc(NASDAQ: ONCE) recently reported that the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee has approved LUXTURNA™ (voretigene…